Tumor cell lines
| . | TARC, pg/mL . | MDC, pg/mL . |
|---|---|---|
| HL | ||
| HDLM-2 | > 2000 | > 4000 |
| L428 | > 2000 | < 62.5 |
| L540 | 691 ± 116 | 285 ± 94 |
| KH-M2 | 918 ± 183 | < 62.5 |
| L1236 | > 2000 | 657 ± 60 |
| ALCL | ||
| Karpas-299 | 93 ± 33 | < 62.5 |
| Karpas-299/TARC | > 2000 | Not done |
| . | TARC, pg/mL . | MDC, pg/mL . |
|---|---|---|
| HL | ||
| HDLM-2 | > 2000 | > 4000 |
| L428 | > 2000 | < 62.5 |
| L540 | 691 ± 116 | 285 ± 94 |
| KH-M2 | 918 ± 183 | < 62.5 |
| L1236 | > 2000 | 657 ± 60 |
| ALCL | ||
| Karpas-299 | 93 ± 33 | < 62.5 |
| Karpas-299/TARC | > 2000 | Not done |
ALCL indicates anaplastic large-cell lymphoma; TARC, thymus- and activation-regulated chemokine; and MDC, macrophage-derived chemokine.